| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Endocrinology and Metabolism, Vol 264, Issue 5 E756-E762, Copyright © 1993 by American Physiological Society
ARTICLES |
P. Nuutila, J. Knuuti, U. Ruotsalainen, V. A. Koivisto, E. Eronen, M. Teras, J. Bergman, M. Haaparanta, L. M. Voipio-Pulkki, J. Viikari and al. et
Department of Medicine, Turku Medical Cyclotron-Positron Emission Tomography Center, University of Turku, Finland.
To determine the tissue localization of insulin resistance in type 1 diabetic patients, whole body and regional glucose uptake rates were determined under euglycemic hyperinsulinemic conditions. Leg, arm, and heart glucose uptake rates were measured using positron emission tomography-derived 2-deoxy-2-[18F]-fluoro-D-glucose kinetics and the three-compartment model described by Sokoloff et al. (L. Sokoloff, M. Reivich, C. Kennedy, M.C. DesRosiers, C.S. Patlak, K.D. Pettigrew, O. Sakurada, and M. Shinohara. J. Neurochem. 28: 897-916, 1977) in eight type 1 diabetic patients and eight matched normal subjects. Whole body glucose uptake was quantitated by the euglycemic insulin clamp technique. Whole body glucose uptake was approximately 31% lower in the diabetic patients (P < 0.01) than in the normal subjects, thus confirming the presence of whole body insulin resistance. The rate of glucose uptake was approximately 45% lower in leg muscle when measured in the femoral region (55 +/- 7 vs. 102 +/- 13 mumol.kg muscle-1.min-1, diabetic patients vs. normal subjects, P < 0.05) and approximately 27% lower in the arm muscles (66 +/- 4 vs. 90 +/- 13 mumol.kg muscle-1.min-1, respectively, P < 0.05), whereas no difference was observed in heart glucose uptake [789 +/- 80 vs. 763 +/- 58 mumol.kg muscle-1.min-1 not significant (NS)]. Whole body glucose uptake correlated with glucose uptake in femoral (r = 0.93, P < 0.005) and arm muscles (r = 0.66, P < 0.05) but not with glucose uptake in the heart (r = 0.04, NS). We conclude that insulin resistance in type 1 diabetic patients is localized to skeletal muscle, whereas heart glucose uptake is unaffected.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  M. Robitaille, M.-C. Dube, S. J. Weisnagel, D. Prud'homme, D. Massicotte, F. Peronnet, and C. Lavoie Substrate source utilization during moderate intensity exercise with glucose ingestion in Type 1 diabetic patients J Appl Physiol, July 1, 2007; 103(1): 119 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. An and B. Rodrigues Role of changes in cardiac metabolism in development of diabetic cardiomyopathy Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1489 - H1506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Iozzo, P. Chareonthaitawee, D. Dutka, D. J. Betteridge, E. Ferrannini, and P. G. Camici Independent Association of Type 2 Diabetes and Coronary Artery Disease With Myocardial Insulin Resistance Diabetes, October 1, 2002; 51(10): 3020 - 3024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Peltoniemi, H. Yki-Järvinen, V. Oikonen, A. Oksanen, T. O. Takala, T. Rönnemaa, M. Erkinjuntti, M. J. Knuuti, and P. Nuutila Resistance to Exercise-Induced Increase in Glucose Uptake During Hyperinsulinemia in Insulin-Resistant Skeletal Muscle of Patients With Type 1 Diabetes Diabetes, June 1, 2001; 50(6): 1371 - 1377. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Peltoniemi, P. Lonnroth, H. Laine, V. Oikonen, T. Tolvanen, T. Gronroos, L. Strindberg, J. Knuuti, and P. Nuutila Lumped constant for [18F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E1122 - E1130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shimoni, D. Severson, and H. S. Ewart Insulin resistance and the modulation of rat cardiac K+ currents Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H639 - H649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Utriainen, S. Lovisatti, S. Makimattila, A. Bertoldo, S. Weintraub, R. DeFronzo, C. Cobelli, and H. Yki-Jarvinen Direct measurement of the lumped constant for 2-deoxy-[1-14C]glucose in vivo in human skeletal muscle Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E228 - E233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. E. Botker, H. Wiggers, M. Bottcher, J. S. Christiansen, T. T. Nielsen, A. Gjedde, and O. Schmitz Short-term effects of growth hormone on myocardial glucose uptake in healthy humans Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1053 - E1059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. O. Takala, P. Nuutila, J. Knuuti, M. Luotolahti, and H. Yki-Jarvinen Insulin action on heart and skeletal muscle glucose uptake in weight lifters and endurance athletes Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E706 - E711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. V.S. Marinho, B. E. Keogh, D. C. Costa, A. A. Lammerstma, P. J. Ell, and P. G. Camici Pathophysiology of Chronic Left Ventricular Dysfunction : New Insights From the Measurement of Absolute Myocardial Blood Flow and Glucose Utilization Circulation, February 15, 1996; 93(4): 737 - 744. [Abstract] [Full Text]
|
|
|
|
|
|
K. Clarke and R. L. Veech Metabolic Complexities in Cardiac Imaging Circulation, May 1, 1995; 91(9): 2299 - 2301. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
